Positive results - chronic toxicity study of ATL1102 in MS
Positive results - chronic toxicity study of ATL1102 in MS
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose)..... Read More - http://www.ms-uk.org/ATL1102
MS-UK - http://www.ms-uk.org/
Re: Positive results - chronic toxicity study of ATL1102 in
Is it China that is using monkeys in this study? I didn't think anyone used monkeys anymore in labs, I thought it was no longer permitted.
- CureOrBust
- Family Elder
- Posts: 3374
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia
Re: Positive results - chronic toxicity study of ATL1102 in
Tread carefully on following this one. Implication to working in a similar way to natalizumab
http://www.drugs.com/clinical_trials/at ... -5608.htmlVLA-4 blockade, as shown by monoclonal antibodies such as natalizumab, prevents activated lymphocytes from migrating into the CNS and significantly reduces disease activity in MS.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1764 Views
-
Last post by NHE
-
- 8 Replies
- 7320 Views
-
Last post by Algis
-
- 1 Replies
- 1199 Views
-
Last post by Scott1
-
- 1 Replies
- 1832 Views
-
Last post by frodo
-
- 0 Replies
- 1728 Views
-
Last post by DIM
-
- 0 Replies
- 1498 Views
-
Last post by frodo
-
- 0 Replies
- 1936 Views
-
Last post by DIM
-
- 0 Replies
- 1853 Views
-
Last post by Tif